Homepage Top
-
Reimbursement of Altuviiio recommended, but…
MONTRÉAL, July 3, 2025 – In June, both Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) released...
-
Kathy Mulder appointed to the Order of Canada
Montréal, July 1, 2025 – On this very special 2025 Canada Day, the CHS could not be prouder as, yesterday, Kathy Mulder, a long-acting volunteer...
-
NEW BOOKLET! All About Novel Therapies
The CHS is very proud to present its latest publication, the first component of its brand-new Novel Therapies Education Program. CLICK HERE to access the online booklet.
-
Health Canada approves Altuviiio
MONTRÉAL, March 31, 2025 – Health Canada has granted marketing approval to Altuviiio (efanesoctocog alfa) for the treatment of hemophilia A in children, adolescents and...
-
James Kreppner Memorial Scholarship and Bursary Program
In an effort to bring young volunteers into the Canadian Hemophilia Society (CHS), and in recognition that a sound education is of utmost importance, particularly...